FUNDAMENTALS |
MarketCap: |
125 439 mill
|
EPS: |
8.77
|
P/E: |
37.55
|
Earnings Date: |
Aug 01, 2024 |
SharesOutstanding: |
380.95 mill
|
Avg Daily Volume: |
1.254 mill
|
RATING
2024-05-08 |
S
|
Strong Buy
|
RATINGS |
Rating CashFlow: |
Buy
|
|
Return On Equity: |
Buy
|
|
Return On Asset: |
Strong Buy
|
|
DE: |
Strong Buy
|
|
P/E: |
Strong Buy
|
|
Price To Book: |
Strong Buy
|
|
QUARTER GROWTHS |
|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
2.43x
|
Company: PE 37.55 | sector: PE 15.43
|
PE RATIO: COMPANY / INDUSTRY |
0.43x
|
Company: PE 37.55 | industry: PE 87.83
|
DISCOUNTED CASH FLOW VALUE |
$201.17
(-38.91%)
$-128.11
|
Date: 2024-05-08
|
Expected Trading Range (DAY) |
$ 323.38 - 335.18
( +/- 1.79%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2024-05-01 | Menon Viju | Sell | 649 | Common Stock |
2024-05-01 | Fink M Kathryn | Sell | 140 | Common Stock |
2024-05-01 | Boehnlein Glenn S | Sell | 585 | Common Stock |
2024-05-01 | Becker Yin C | Sell | 148 | Common Stock |
2024-03-21 | Stiles Spencer S | Buy | 203 | Common Stock |
INSIDER POWER |
-59.96
|
Last
100 transactions |
Buy:
371 226 | Sell:
1 489 951 |
Forecast:
16:00 - $329.28
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $329.28
Forecast 2: 16:00 - $329.28
Forecast 3: 16:00 - $329.28
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$329.28 (-0.86% )
|
Volume |
0.938 mill
|
Avg. Vol. |
1.254 mill
|
% of Avg. Vol |
74.77 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For SYK
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.